Mast cells density positive to tryptase correlates with angiogenesis in pancreatic ductal adenocarcinoma patients having undergone surgery

Gastroenterology Research and Practice

Volumn 2014, Issue , 2014, Pages

  Ammendola, Michele ^a,b   Sacco, Rosario ^a   Sammarco, Giuseppe ^a   Donato, Giuseppe ^a   Zuccalà, Valeria ^a   Luposella, Maria ^a   Patruno, Rosa ^b   Marech, Ilaria ^b   Montemurro, Severino ^b   Zizzo, Nicola ^c   Gadaleta, Cosmo Damiano ^b   Ranieri, Girolamo ^b  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b National Cancer Research Centre   (Italy)

^c UNIVERSITY OF BARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; GEMCITABINE; TRYPTASE;

AGED; ANGIOGENESIS; ANTIANGIOGENIC THERAPY; ARTICLE; CANCER STAGING; CELL DENSITY; CLINICAL ARTICLE; CORRELATION ANALYSIS; FEMALE; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; MALE; MAST CELL; PANCREAS ADENOCARCINOMA; PANCREAS RESECTION; PANCREATICODUODENECTOMY; PILOT STUDY;

EID: 84903625003     PISSN: 16876121     EISSN: 1687630X     Source Type: Journal    
DOI: 10.1155/2014/951957     Document Type: Article

References (45)

1. Ranieri G., Labriola A., Achille G., Florio G., Zito A. F., Grammatica L., Paradiso A., Microvessel density, mast cell density and thymidine phosphorylase expression in oral squamous carcinoma. International Journal of Oncology 2002 21 6 1317 1323 2-s2.0-0042754636
2. Ranieri G., Ammendola M., Patruno R., Celano G., Zito F. A., Montemurro S., Rella A., Di Lecce V., Gadaleta C. D., De Sarro G. B., Ribatti D., Tryptase-positive mast cells correlate with angiogenesis in early breast cancer patients. International Journal of Oncology 2009 35 1 115 120 2-s2.0-67649422130 10.3892/ijo-00000319
3. Weidner N., Semple J. P., Welch W. R., Folkman J., Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. The New England Journal of Medicine 1991 324 1 1 8 2-s2.0-0026083903
4. Kankkunen J. P., Harvima I. T., Naukkarinen A., Quantitative analysis of tryptase and chymase containing mast cells in benign and malignant breast lesions. International Journal of Cancer 1997 72 3 385 338
5. Soucek L., Lawlor E. R., Soto D., Shchors K., Swigart L. B., Evan G. I., Mast cells are required for angiogenesis and macroscopic expansion of Myc-induced pancreatic islet tumors. Nature Medicine 2007 13 10 1211 1218 2-s2.0-34948852371 10.1038/nm1649 (Pubitemid 47530639)
6. Ribatti D., Ranieri G., Nico B., Benagiano V., Crivellato E., Tryptase and chymase are angiogenic in vivo in the chorioallantoic membrane assay. International Journal of Developmental Biology 2011 55 1 99 102 2-s2.0-79952087115 10.1387/ijdb.103138dr
7. Mangia A., Malfettone A., Rossi R., Paradiso A., Ranieri G., Simone G., Resta L., Tissue remodelling in breast cancer: human mast cell tryptase as an initiator of myofibroblast differentiation. Histopathology 2011 58 7 1096 1106 2-s2.0-79959751459 10.1111/j.1365-2559.2011.03842.x
8. Ranieri G., Gadaleta-Caldarola G., Goffredo V., Patruno R., Mangia A., Rizzo A., Sciorsci R. L., Gadaleta C. D., Sorafenib (BAY 43-9006) in hepatocellular carcinoma patients: from discovery to clinical development. Current Medicinal Chemistry 2012 19 7 938 944 2-s2.0-84858164702
9. Goffredo V., Gadaleta C. D., Laterza A., Vacca A., Ranieri G., Tryptase serum levels in patients suffering from hepatocellular carcinoma undergoing intra-arterial chemoembolization: possible predictive role of response to treatment. Molecular and Clinical Oncology 2013 1 2 385 389
10. Ranieri G., Passantino L., Patruno R., Passantino G., Jirillo F., Catino A., Mattioli V., Gadaleta C., Ribatti D., The dog mast cell tumour as a model to study the relationship between angiogenesis, mast cell density and tumour malignancy. Oncology Reports 2003 10 5 1189 1193 2-s2.0-2142687616
11. Raneri G., Achille G., Florio G., Biological-clinical significance of angiogenesis and mast cell infiltration in squamous cell carcinoma of the oral cavity. Acta Otorhinolaryngologica Italica 2001 21 3 171 178
12. Gulubova M., Vlaykova T., Prognostic significance of mast cell number and microvascular density for the survival of patients with primary colorectal cancer. Journal of Gastroenterology and Hepatology 2009 24 7 1265 1275 2-s2.0-68749085163 10.1111/j.1440-1746.2007.05009.x
13. Ammendola M., Sacco R., Sammarco G., Mast cells positive to tryptase and C-Kit receptor expressing cells correlates with angiogenesis in gastric cancer patients surgically treated. Gastroenterology Research and Practice 2013 2013 5 10.1155/2013/703163 703163
14. Ammendola M., Sacco R., Donato G., Zuccalà V., Russo E., Luposella M., Vescio G., Rizzuto A., Patruno R., De Sarro G., Montemurro S., Sammarco G., Ranieri G., Mast cell positivity to tryptase correlates with metastatic lymph nodes in gastrointestinal cancer patients treated surgically. Oncology 2013 85 2 111 116 2-s2.0-84880405739 10.1159/000351145
15. Ma Y., Ullrich S. E., Intratumoral mast cells promote the growth of pancreatic cancer. Oncoimmunology 2013 1 2 e25964
16. Ma Y., Hwang R. F., Logsdon C. D., Ullrich S. E., Dynamic mast cell-stromal cell interactions promote growth of pancreatic cancer. Cancer Research 2013 73 13 3927 3937 2-s2.0-84880074843 10.1158/0008-5472.CAN-12-4479
17. Ranieri G., Grammatica L., Patruno R., Zito A. F., Valerio P., Iacobellis S., Gadaleta C., Gasparini G., Ribatti D., A possible role of thymidine phosphorylase expression and5-fluorouracil increased sensitivity in oropharyngeal cancer patients. Journal of Cellular and Molecular Medicine 2007 11 2 362 368 2-s2.0-34247882636 10.1111/j.1582-4934.2007.00007.x (Pubitemid 46693334)
18. Kondo K., Muramatsu M., Okamoto Y., Jin D., Takai S., Tanigawa N., Miyazaki M., Expression of chymase-positive cells in gastric cancer and its correlation with the angiogenesis. Journal of Surgical Oncology 2006 93 1 36 42 2-s2.0-29844458158 10.1002/jso.20394 (Pubitemid 43038424)
19. Ribatti D., Vacca A., Nico B., Quondamatteo F., Ria R., Minischetti M., Marzullo A., Herken R., Roncali L., Dammacco F., Bone marrow angiogenesis and mast cell density increase simultaneously with progression of human multiple myeloma. British Journal of Cancer 1999 79 3-4 451 455 2-s2.0-0032903871 10.1038/sj.bjc.6690070 (Pubitemid 29046218)
20. Tuna B., Yorukoglu K., Unlu M., Mungan M. U., Kirkali Z., Association of mast cells with microvessel density in renal cell carcinomas. European Urology 2006 50 3 530 534 (Pubitemid 44189044)
21. Galli S. J., Mast cells and basophils. Current Opinion in Hematology 2000 1 7 32 39 (Pubitemid 30007685)
22. Qu Z., Liebler J. M., Powers M. R., Galey T., Ahmadi P., Huang X.-N., Ansel J. C., Butterfield J. H., Planck S. R., Rosenbaum J. T., Mast cells are a major source of basic fibroblast growth factor in chronic inflammation and cutaneous hemangioma. American Journal of Pathology 1995 147 3 564 573 2-s2.0-0029117071
23. Grützkau A., Krüger-Krasagakes S., Kögel H., Möller A., Lippert U., Henz B. M., Detection of intracellular interleukin-8 in human mast cells: flow cytometry as a guide for immunoelectron microscopy. Journal of Histochemistry and Cytochemistry 1997 45 7 935 945 2-s2.0-0030747665 (Pubitemid 27284017)
24. Thomas P. S., Pennington D. W., Schreck R. E., Levine T. M., Lazarus S. C., Authentic 17 kDa tumour necrosis factor α is synthesized and released by canine mast cells and up-regulated by stem cell factor. Clinical and Experimental Allergy 1996 26 6 710 718 2-s2.0-0030002564 10.1111/j.1365-2222. 1996.tb00598.x (Pubitemid 26226586)
25. Sörbo J., Jakobsson A., Norrby K., Mast-cell histamine is angiogenic through receptors for histamine1 and histamine2. International Journal of Experimental Pathology 1994 75 1 43 50 2-s2.0-0028362204 (Pubitemid 24197569)
26. Blair R. J., Meng H., Marchese M. J., Ren S., Schwartz L. B., Tonnesen M. G., Gruber B. L., Human mast cells stimulate vascular tube formation. Tryptase is a novel, potent angiogenic factor. Journal of Clinical Investigation 1997 99 11 2691 2700 2-s2.0-0031010717 (Pubitemid 27259816)
27. Grützkau A., Krüger-Krasagakes S., Baumeister H., Schwarz C., Kögel H., Welker P., Lippert U., Henz B. M., Möller A., Synthesis, storage, and release of vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) by human mast cells: implications for the biological significance of VEGF206. Molecular Biology of the Cell 1998 9 4 875 884 2-s2.0-0005015714 (Pubitemid 28173640)
28. Wang X., Chen X., Fang J., Yang C., Overexpression of both VEGF-A and VEGF-C in gastric cancer correlates with prognosis, and silencing of both is effective to inhibit cancer growth. International Journal of Clinical and Experimental Pathology 2013 6 4 586 597 2-s2.0-84878477682
29. Zhao Y., Wu K., Cai K., Zhai R., Tao K., Wang G., Wang J., Increased numbers of gastric-infiltrating mast cells and regulatory T cells are associated with tumor stage in gastric adenocarcinoma patients. Oncology Letters 2012 4 4 755 758 2-s2.0-84864646479 10.3892/ol.2012.830
30. Mukherjee S., Bandyopadhyay G., Dutta C., Bhattacharya A., Karmakar R., Barui G., Evaluation of endoscopic biopsy in gastric lesions with a special reference to the significance of mast cell density. Indian Journal of Pathology and Microbiology 2009 52 1 20 24 2-s2.0-58849086703 10.4103/0377-4929.44956
31. Ammendola M., Zuccalà V., Patruno R., Russo E., Luposella M., Amorosi A., Vescio G., Sammarco G., Montemurro S., De Sarro G., Sacco R., Ranieri G., Tryptase-positive mast cells and angiogenesis in keloids: a new possible post-surgical target for prevention. Updates in Surgery 2013 65 1 53 57 2-s2.0-84874638055 10.1007/s13304-012-0183-y
32. Nico B., Mangieri D., Crivellato E., Vacca A., Ribatti D., Mast cells contribute to vasculogenic mimicry in multiple myeloma. Stem Cells and Development 2008 17 1 19 22 2-s2.0-39449125282 10.1089/scd.2007.0132 (Pubitemid 351271616)
33. Fajardo I., Pejler G., Human mast cell β -tryptase is a gelatinase. Journal of Immunology 2003 171 3 1493 1499 2-s2.0-0041845040 (Pubitemid 36900084)
34. Chang D. Z., Ma Y., Ji B., Wang H., Deng D., Liu Y., Abbruzzese J. L., Liu Y.-J., Logsdon C. D., Hwu P., Mast cells in tumor microenvironment promotes the in vivo growth of pancreatic ductal adenocarcinoma. Clinical Cancer Research 2011 17 22 7015 7023 2-s2.0-81255138309 10.1158/1078-0432.CCR-11-0607
35. Cai S.-W., Yang S.-Z., Gao J., Pan K., Chen J.-Y., Wang Y.-L., Wei L.-X., Dong J.-H., Prognostic significance of mast cell count following curative resection for pancreatic ductal adenocarcinoma. Surgery 2011 149 4 576 584 2-s2.0-79952709160 10.1016/j.surg.2010.10.009
36. Tod J., Jenei V., Thomas G., Fine D., Tumor-stromal interactions in pancreatic cancer. Pancreatology 2013 13 1 1 7 10.1016/j.pan.2012.11.311
37. Strouch M. J., Cheon E. C., Salabat M. R., Crosstalk between mast cells and pancreatic cancer cells contributes to pancreatic tumor progression. Clinical Cancer Research 2010 16 8 2257 2265 10.1158/1078-0432.CCR-09-1230
38. Strouch M. J., Cheon E. C., Salabat M. R., Krantz S. B., Gounaris E., Melstrom L. G., Dangi-Garimella S., Wang E., Munshi H. G., Khazaie K., Bentrem D. J., Crosstalk between mast cells and pancreatic cancer cells contributes to pancreatic tumor progression. Clinical Cancer Research 2010 16 8 2257 2265 2-s2.0-77950968790 10.1158/1078-0432.CCR-09-1230
39. Protti M. P., De Monte L., Immune infiltrates as predictive markers of survival in pancreatic cancer patients. Frontiers in Physiology 2013 4article 210
40. Evans A., Costello E., The role of inflammatory cells in fostering pancreatic cancer cell growth and invasion. Frontiers in Physiology 2012 3, article 270 2-s2.0-84866450512 10.3389/fphys.2012.00270
41. Esposito I., Menicagli M., Funel N., Bergmann F., Boggi U., Mosca F., Bevilacqua G., Campani D., Inflammatory cells contribute to the generation of an angiogenic phenotype in pancreatic ductal adenocarcinoma. Journal of Clinical Pathology 2004 57 6 630 636 2-s2.0-2642547301 10.1136/jcp.2003.014498 (Pubitemid 38725766)
42. Erba F., Fiorucci L., Pascarella S., Menegatti E., Ascenzi P., Ascoli F., Selective inhibition of human mast cell tryptase by gabexate mesylate, an antiproteinase drug. Biochemical Pharmacology 2001 61 3 271 276 2-s2.0-0035253833 10.1016/S0006-2952(00)00550-5 (Pubitemid 32126664)
43. Mori S., Itoh Y., Shinohata R., Sendo T., Oishi R., Nishibiro M., Nafamostat mesilate is an extremely potent inhibitor of human tryptase. Journal of Pharmacological Sciences 2003 92 4 420 423 2-s2.0-0041694064 (Pubitemid 37086724)
44. Humbert M., Castéran N., Letard S., Hanssens K., Iovanna J., Finetti P., Bertucci F., Bader T., Mansfield C. D., Moussy A., Hermine O., Dubreuil P., Masitinib combined with standard gemcitabine chemotherapy: in vitro and in vivo studies in human pancreatic tumour cell lines and ectopic mouse model. PLoS ONE 2010 5 3 2-s2.0-77950128955 10.1371/journal.pone.0009430 e9430
45. Marech I., Patruno R., Zizzo N., Masitinib (AB1010), from canine tumou model to human clinical development: where we are? Critical Reviews in Oncology/Hematology 2013 S1040-8428 13 00266 00267 10.1016/j.critrevonc.2013